Today's Daily Dose brings you news about Cabaletta Bio's Pemphigus Vulgaris drug candidate, DBV Technologies' stock offering, the progress of Immutep's pipeline and the decision of Spring Bank to halt the development of its HBV drug candidate.
from RTT - Top Story https://ift.tt/3aTl456
via IFTTT
from RTT - Top Story https://ift.tt/3aTl456
via IFTTT
Comments
Post a Comment